Daiwa Securities Group Inc. Eloxx Pharmaceuticals, Inc. Transaction History

Daiwa Securities Group Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$3.19 - $7.56 $711 - $1,685	-223 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$10.45 - $13.94 $1,849 - $2,467	-177 Reduced 44.25%	223 $3,000
Q4 2018 Feb 05, 2019	BUY	$10.43 - $17.39 $4,172 - $6,956	400 New	400 $5,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.